Edgewise Therapeutics, Inc. (NasdaqGS: EWTX)
Health Care · Pharmaceuticals · US
$39.06
-0.43% today · +143.4% 1Y
Edgewise Therapeutics, Inc. (NasdaqGS: EWTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.24B and employs 127 people.
Over the last twelve months the share price has gained 143.4%, trading between 14.25 and 48.51.
Tweenvest scores Edgewise Therapeutics, Inc. across four factors: quality 40/100, value 74/100. Its strongest factor is value.
EWTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.24B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.85
- Dividend yield
- —
- Beta (5Y)
- 0.36
- 52-week high
- $48.51
- 52-week low
- $14.25
- Avg volume (3M)
- —
- Shares outstanding
- 108.60M
- Employees
- 127
- Next earnings
- —
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
- ISIN
- US28036F1057
- Founded
- 2017
- Listed since
- Mar 26, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dottikon ES Holding AGSWX: DESN | $4.32B | CHF260.00 | +1.36% |
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.31B | CN¥71.90 | +3.86% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.27B | CN¥25.40 | -8.44% |
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.25B | R158.26 | -1.09% |
| Sam Chun Dang Pharm. Co., LtdKOSDAQ: A000250 | $4.24B | ₩243,500.00 | +17.63% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.23B | ₩72,700.00 | -4.09% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.23B | $35.83 | +1.07% |
| Yuhan CorporationKOSE: A000100 | $4.06B | ₩73,100.00 | -1.35% |
Figures last refreshed Oct 11, 2026.